Skip to content
Biotech For FIRE
  • Biotech
  • Holorogy
  • Investing
  • Book Review
  • News
  • About Me
  • Subscribe
  • Contact

RPRX

  • Home
  • RPRX

$RPRX: Curious case of insider activities at Royalty Pharma (CEO buying, but everyone else is selling)

Posted by By biotechwarrior June 10, 2023Posted inTalking about BiotechNo Comments
Royalty Pharma is an interesting business - despite the "pharma" letter in the name, it is not a pharma, but it is an investment firm that buys royalties. However, Royalty…
Read More
Recent posts
  • Pharma update: Bullish for 4Q24
  • Immunology market update (positive: $ABBV $UCB / negative: $JNJ, $NVS, $LLY, $BMY, $AMGN)
  • REGN’s CRL and its impact on wet AMD market: 2H23 Biotech/Pharma outlook
  • 2H23 Pharma/Biotech Outlook (Part. 1)
  • $RPRX: Curious case of insider activities at Royalty Pharma (CEO buying, but everyone else is selling)

Loading
Follow Us
  • X
About Me
Logo
Former Biotech hedge fund analyst turned internet writer. Biotech can be fun and help with our FIRE plan. Still got a long way to go and wanted to share my journey. I am a Baker Brother wannabe. You can reach me at biotechwarrior@biotechforfire.tech
Subscribe for the latest posts

Loading
Useful Links
  • Endpoints News
  • FiercePharma
  • FierceBiotech
Copyright 2026 — Biotech For FIRE. All rights reserved. Sinatra WordPress Theme
Scroll to Top